Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Canine PD-L1
- Development stage
- Preclinical
- Lead developer
- Nexvet Biopharm
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
Canine PD-L1 (NodCure-PD-L1-Cancer) is a veterinary oncology therapeutic candidate developed by NodCure for the treatment of cancer in dogs. It is a monoclonal antibody designed to target and inhibit the Programmed death-ligand 1 (PD-L1) immune checkpoint. PD-L1 is a protein often overexpressed by cancer cells to suppress the host's immune response by binding to PD-1 receptors on T-cells. By blocking this interaction, the drug aims to restore the anti-tumor activity of the canine immune system, allowing T-cells to recognize and destroy malignant cells. The program is currently in the IND-enabling phase, which includes toxicity studies and investigator-initiated trials (IIT).
- Other names
- NodCure-PD-L1-Cancer (canine)Canine PD-L1 antibody
02
Targets
CD274 (Programmed cell death protein 1 ligand 1)
Beyond the preview
Go deeper on Canine PD-L1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Canine PD-L1.